AmplifyMD, the fast-growing telehealth platform focused on smarter virtual care for hospitals and health systems, has secured $20 million in a Series B round. The funding was led by Forerunner, F-Prime, Greylock Partners, Tau Ventures, and Memorial Hermann Health System, signaling strong confidence in the company’s mission to bring efficiency and high-quality virtual care to healthcare organizations nationwide.

Founded by Meena Mallipeddi, AmplifyMD has built its reputation around enabling hospitals to do more with less while still maintaining consistent, reliable patient care. The platform provides hospitals and health systems with direct access to a wide range of specialists, helping them overcome one of the most critical challenges in modern healthcare: the shortage of specialty providers.

Tackling the specialist shortage head-on

Specialist shortages continue to put pressure on hospitals, particularly in fields like neurology, cardiology, psychiatry, and critical care. These gaps often lead to delayed diagnoses, higher transfer rates, and significant strain on both staff and patients. AmplifyMD was designed to close this gap by creating a scalable telehealth infrastructure that connects hospitals with board-certified specialists on demand.

Rather than forcing hospitals to hire full-time specialists for every department - a costly and often impossible task - AmplifyMD integrates into existing workflows, giving organizations reliable access to expertise exactly when and where it’s needed. This model not only improves patient outcomes but also reduces operational inefficiencies, making it a highly practical solution in an increasingly strained healthcare environment.

Building a seamless model for adoption

While telemedicine has seen widespread adoption since the pandemic, many solutions remain fragmented, requiring hospitals to juggle multiple platforms and providers. AmplifyMD’s strength lies in its ability to unify specialty care delivery under one system, reducing the complexity and friction that often slow down digital healthcare transformations.

And this is where founders can find a powerful lesson. What AmplifyMD got right from the very beginning wasn’t just the technology itself, but the removal of friction in adoption. Hospitals already operate within highly complex systems filled with legacy processes, entrenched workflows, and strict regulations. By embedding its solution directly into hospital operations instead of requiring drastic behavioral changes, AmplifyMD made adoption feel natural. Too often, startups try to win with the “best product,” forgetting that enterprise customers value continuity just as much as innovation. AmplifyMD’s growth illustrates that reducing the cost of change for your customers can be a bigger lever than building the flashiest features. For founders, this is a critical insight: make your solution so easy to integrate that it feels like it’s always been there, and scaling becomes exponentially faster.

Strong backing from top investors

The participation of investors such as Forerunner, F-Prime, and Greylock Partners provides AmplifyMD with deep expertise in scaling transformative businesses. Their support demonstrates conviction in the company’s ability to solve one of healthcare’s most pressing problems while building a business with strong growth potential.

Strategic involvement from Memorial Hermann Health System adds an extra layer of validation. As one of the largest healthcare systems in the United States, Memorial Hermann represents both a key customer and a partner that can help AmplifyMD refine and expand its offerings in real-world hospital settings. This dual advantage of financial and strategic backing creates a powerful foundation for the company’s next phase of growth.

Scaling impact across the healthcare ecosystem

With this new funding, AmplifyMD plans to expand its specialist network, enhance platform capabilities, and onboard more hospitals across the country. The company’s focus on reducing unnecessary patient transfers, improving care outcomes, and optimizing staff efficiency makes it an attractive partner for health systems under increasing financial and operational pressure.

Importantly, the platform also helps address healthcare inequities. Rural and underserved hospitals often lack access to critical specialists, forcing patients to travel long distances or face delayed care. AmplifyMD’s model democratizes access by making top-tier specialty care available regardless of geography, ensuring more patients receive the care they need when they need it.

Mission-driven leadership

At the center of AmplifyMD’s success is CEO Meena Mallipeddi, whose mission-driven leadership has been instrumental in shaping the company’s vision. Her focus on marrying advanced technology with operational empathy for hospitals has enabled AmplifyMD to stand out in a crowded healthcare tech space. By listening closely to the needs of hospital partners and prioritizing seamless integration, she has built not just a product but a system of trust between healthcare providers and the technology that supports them.

Looking ahead

As AmplifyMD leverages its $20 million Series B, the company is poised to expand nationally, broaden its specialty offerings, and deepen partnerships with leading healthcare organizations. By solving one of healthcare’s most persistent bottlenecks - access to specialists - AmplifyMD is positioned at the intersection of necessity and innovation.

For founders across industries, the story of AmplifyMD highlights an essential truth: success doesn’t just come from building something powerful, it comes from building something that customers can adopt without friction. The lesson is simple but transformative - the easier you make adoption, the faster your customers will champion your growth.